79 results
Page 3 of 4
8-K
EX-10.1
eqiyyr0ih9yln7 d0jf
7 Feb 19
Entry into a Material Definitive Agreement
5:27pm
DEFM14A
2tyoagyd9b6b4w6bsv
6 Nov 18
Proxy related to merger
12:00am
424B3
zfm4 dy46jo1wkk
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
shz1 0eg2k
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.1
7j9tg agwlgkuca6dhe
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
t93p6bp3 ydp
9 Aug 18
Business combination disclosure
5:17pm
8-K
EX-1.1
en0ux0zmhzbis
8 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
hal4qp 6p7rktsz88v1u
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
424B3
0zy rggxto3ozullhoik
13 Sep 13
Prospectus supplement
12:00am
424B3
bm2nv3q
13 Sep 13
Prospectus supplement
12:00am